Information Technology Today
Thursday, November 19, 2026
NETWORK CONCERNS DELAY 72 PCT OF AI PROJECTS - OPENGEAR RESEARCH
Opengear President, Patrick Quirk said the industry has traditionally treated resilience as a response to failure, but this research showed it is also a source of business performance.
“As networks stretch across data centres, cloud, branch and edge locations, the ability to keep secure access and control over them is becoming one of the clearest measures of how well a business can operate and grow,” he added in a statement.
The research found that organisations with embedded network resilience reported average estimated outage costs around US$6 million lower over the past 12 months than those with less developed capabilities (US$12.4 million versus US$18.8 million). (US$1 = RM4.11)
Organisations with embedded resilience were also nearly twice as likely to have secure remote access and recovery capabilities in place before AI or edge deployment, with nearly all having already deployed such infrastructure, compared with about four in five organisations with less developed capabilities.
The survey covered 514 chief information officers (CIOs) and chief information security officers (CISOs) in the United States, United Kingdom, Germany, India and Australia in July and August 2026. Respondents were grouped as embedded or reactive based on their ability to remotely access and recover critical infrastructure, test recovery without the primary network and reduce reliance on sending engineers onsite.
Embedded organisations were roughly half as likely to report deployment delays of four days or more, at 21 per cent compared with 39 per cent among reactive organisations. They were also more confident in maintaining access, visibility and control during routine infrastructure changes, with 49 per cent expressing strong confidence compared with 28 per cent.
During cyber incidents, 93 per cent of embedded organisations were confident they could isolate affected systems while maintaining access to unaffected infrastructure, compared with 74 per cent of reactive organisations.
The research also found that 84 per cent of embedded organisations agreed network resilience was becoming more important as AI and edge infrastructure expanded. Supporting AI, edge or distributed infrastructure growth was also their leading investment priority for the next 12 months.
-- BERNAMA
Tuesday, November 17, 2026
H2O.AI LAUNCHES TWO NEW PREDICTIVE AI FOUNDATION MODELS
KUALA LUMPUR, Nov 18 (Bernama) -- H2O.ai has launched the next version of its predictive artificial intelligence (AI) capabilities, adding two new foundation models, TimeH2O for time-series data and TabH2O for tabular data.
TimeH2O is a 108-million-parameter time-series foundation model that makes zero-shot forecasts, allowing it to predict outcomes using data it has never encountered without requiring a separate model for each dataset. Organisations can fine-tune it using their own data for demand forecasting, inventory and financial planning.
Meanwhile, TabH2O, a tabular foundation model, supports predictions using structured business data for applications such as risk scoring, fraud detection and customer analytics. Both models join H2O Driverless AI, an automated machine learning (AutoML) tool, in the company's predictive AI capabilities.
According to H2O.ai in a statement, most organisational decisions involve time-series and tabular data, including demand, inventory, cash flow, risk and fraud, with each forecast or prediction previously requiring a separate model to be built and maintained.
TimeH2O-v1 ranked first among 32 models on the fev-bench forecasting leaderboard as of Oct 23, with a 91.9 per cent win rate, despite not being trained on any fev-bench dataset.
H2O MLOps, a model deployment and monitoring tool, enables organisations to deploy TimeH2O and TabH2O on H2O AI Cloud, fine-tune them using their own data and manage their entire model lifecycle with built-in monitoring and audit capabilities.
Organisations can also choose their deployment environments through H2O AI Managed Cloud, operated by H2O.ai; H2O AI Hybrid Cloud, which supports private cloud, on-premises and air-gapped environments; or H2O AI Cloud for Government, which is FedRAMP High certified.
TimeH2O and TabH2O are now generally available on H2O AI Cloud for production use and fine-tuning using organisations' own data. However, production use of TimeH2O-v1's open weights requires a licence from H2O.ai.
-- BERNAMA
Monday, November 16, 2026
Bitget Launches rToken Earn, Bringing Onchain Yield to Tokenized ETFs with Bitwise Set to Curate the Strategy
rToken Earn extends the use of Reality-issued rTokens beyond trading and collateral. Users can subscribe to vaults for rSPY and rQQQ through their existing Bitget account. Bitget handles subscriptions and redemptions on their behalf, with no fixed subscription term.
Bitwise Investment Manager, LLC, a wholly owned subsidiary of Bitwise Asset Management, is set to curate the vault strategy. Ember Protocol will provide the underlying vault infrastructure, while Fluid will supply the lending markets and liquidity used by the strategy. Underpinning it all will be rTokens themselves, issued by Reality and backed 1:1 by the corresponding securities. Yields are variable and not guaranteed.
“An asset should not be limited to just one purpose,” said Gracy Chen, CEO of Bitget. “With rToken Earn, users can maintain their exposure to ETFs like the S&P 500 and Nasdaq-100 trackers while accessing onchain yield through the same Bitget account. With Universal Exchange, we aim to give users more ways to put their assets to work without moving between platforms.”
The launch follows further expansion of Bitget’s tokenized equities offering in 2026. DeFiLlama Research recorded more than $1.86 billion in cumulative rToken trading volume between June and July. In October, Bitget introduced rToken Stock Transfer, enabling eligible users to convert supported brokerage holdings into rTokens through a two-step process.
“Tokenizing equities is the first step towards onchain finance. Putting them to work comes next,” said Jonathan Man, Portfolio Manager, Head of Multi-Strategy Solutions & DeFi Strategies, Bitwise. “We’re set to curate a strategy that connects tokenized ETF exposure with onchain lending opportunities.”
“The best financial infrastructure is the kind users never have to think about,” said Ibra Barbery, Co-Founder, Ember. “Ember was built so that asset managers can run professional strategies onchain with the controls and security that it requires, and so that platforms like Bitget can offer those strategies through an experience their users already know. Seeing tokenized ETFs move onto that infrastructure is a clear sign of where onchain wealth management is heading.”
“Lending has always been one of the engines of capital markets, and onchain it can run with full transparency,” said Samyak Jain, Founder and CEO, Fluid. “Bringing tokenized ETFs into Fluid extends our liquidity layer to some of the most widely held assets in traditional finance, and shows what becomes possible when real-world assets and DeFi share the same infrastructure.”
rToken Earn is available from today to eligible non-U.S. users, starting with rQQQ and rSPY. Yields are variable and not guaranteed, and availability depends on jurisdiction and eligibility. The strategy curation service from Bitwise is not available at launch and will roll out at a later date.
For more information about Bitget rToken Earn, visit here.
About Bitget
Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP™. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.
About Reality
Reality is a regulated real-world asset issuance platform built for global markets, and is proudly part of the Bitget ecosystem. Working with licensed brokers across major exchanges, including Nasdaq and the NYSE, we purchase and hold the underlying assets in custody, then issue the corresponding rights on-chain. This connects traditional capital markets with on-chain infrastructure, opening institutional-grade access to real-world assets for users worldwide.
About Bitwise
Bitwise Asset Management is a global crypto asset manager with more than $14 billion in client assets. It manages a suite of over 70 investment products in the U.S. and Europe, spanning ETPs, index funds, alpha and SMA strategies, vaults, and staking solutions. Bitwise Investment Manager, LLC (“BIM”), a wholly owned subsidiary of Bitwise Asset Management, provides strategy curation services to vaults. BIM is an investment adviser registered with the U.S. Securities and Exchange Commission, a commodity pool operator and commodity trading advisor registered with the Commodity Futures Trading Commission, and a member of the National Futures Association.
About Ember
Ember is a decentralized vaults infrastructure protocol that unifies cross-chain yield strategies, structured products, and tokenized assets into one platform, making liquidity accessible, transparent, and trustless. It is building the foundation and infrastructure to democratize wealth management.
About Fluid
Fluid is an onchain liquidity layer that combines lending, borrowing and trading in a single system. Fluid holds $4B+ in deposits and has processed $240B+ in trading volume since launch. It powers Jupiter Lend, the largest lending market on Solana, and is live across Ethereum, Arbitrum, Base, Polygon, Plasma and Solana.
About Tether
Tether is a pioneer in the field of stablecoin technology, driven by an aim to revolutionize the global financial landscape. With a mission to provide accessible and efficient financial, communication, artificial intelligence, and energy infrastructure. Tether enables greater financial inclusion, and communication resilience, fosters economic growth, and empowers individuals and businesses alike. As the creator of the largest, most transparent, and liquid stablecoin in the industry, Tether is dedicated to building sustainable and resilient infrastructure for the benefit of underserved communities. By leveraging cutting-edge blockchain and peer-to-peer technology, it is committed to bridging the gap between traditional financial systems and the potential of decentralized finance.
For more information, visit: Website | X | Telegram | LinkedIn | Discord
For media inquiries, please contact: media@bitget.com
Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.
Bitwise Disclosures
No Offer; Access Restrictions. Nothing on this page constitutes an offer to sell, or a solicitation of an offer to buy, any security or financial instrument in any jurisdiction. This page is for informational purposes only and does not constitute investment, financial, legal, or tax advice. rQQQ and rSPY have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States or to U.S. Persons. Prospective depositors should consult their own professional advisers before depositing. This vault is available only to non-U.S. Persons as defined in Rule 902(k) of Regulation S under the Securities Act of 1933. Geofencing and access controls are implemented by Ember Protocol. By depositing, you represent that you are not a U.S. Person, are not acting for the account or benefit of a U.S. Person, are not in a sanctioned jurisdiction, and acknowledge that rQQQ and rSPY have not been registered under the Securities Act. No transfer restrictions are enforced at the smart-contract level; you are responsible for continued compliance. Breach of eligibility representations triggers the indemnification obligations in the Bitwise Onchain Terms of Use.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d5d8dadf-a785-46fa-bf72-2c5288a9573e
SOURCE: Bitget Limited
DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.
Sunday, November 15, 2026
&TRUTH UNVEILS INTERACTIVE MAP TO TRACK SOFTWARE SAFETY
KUALA LUMPUR, Nov 13 (Bernama) -- Public benefit corporation &Truth has unveiled &Atlas, an interactive map of over 100 million lines of open-source C software spanning more than 3,000 foundational codebases.
The map tracks the company’s progress towards mathematically proving that critical software is safe, beginning with C, which underpins operating systems, browsers, databases and networks, according to &Truth in a statement.
Users can explore codebases and their dependencies and see which code has been analysed, which has been mathematically verified and which bugs have been found, although the company said the map does not suggest the entire ecosystem is already secure.
“Finding bugs is just the beginning. Our goal is to fix them, properly coordinate reporting, and mathematically prove that entire classes of failures will never recur in the code we verify,” said &Truth Co-Founder, Co-Chief Executive Officer and Executive Chairman, Chris Hsu.
&Truth said it has verified more than 100,000 lines of C code so far and found numerous real-world defects, which it is working with software maintainers to fix through coordinated disclosure, without publicly exposing unresolved security issues.
The company said the need to prove what code can and cannot do is increasingly urgent as artificial intelligence speeds up both software development and cyberattacks.
&Truth plans to extend its work to other languages, including Rust, Java, Go and C++, and from open-source to enterprise software.
-- BERNAMA
Wednesday, November 11, 2026
HTC’s VIVERSE Invites University Students To Game Hackathon
KUALA LUMPUR, Nov 11 (Bernama) -- HTC’s web-based game platform VIVERSE is holding its global university hackathon, VIVERSE Spark, for a second year, inviting university students worldwide to build games and interactive experiences for cash prizes.
The competition runs from Nov 9 to Dec 4, with judging from Dec 7 to 18 and winners to be announced in early January 2027, according to a statement.
VIVERSE Head of Growth, Andranik Aslanyan said the competition gives students the freedom to experiment, collaborate and create experiences that anyone in the world can enjoy in a web browser.
“We saw a lot of creativity in our first university hackathon last year. We look forward to welcoming a new wave of student creators and giving them the opportunity to develop valuable career skills, build a portfolio, and win prizes,” he said.
Students can enter in teams of one to five members from the same university, in three categories: games, immersive storytelling and social experiences. Entries will be judged on creativity, scene design, technical skill, user experience and user engagement.
Content created on VIVERSE can be played in web browsers on computers, smartphones, tablets and extended reality headsets without installing software, and the platform is designed for students of all experience levels.
-- BERNAMA
KRANESHARES AI FUND BEATS NASDAQ-100, HELPED BY ANTHROPIC STAKE
The fund, which trades under the ticker AGIX, returned 70.13 per cent from its inception on July 17, 2024, to Oct 31, 2026, compared with 45.64 per cent for the Nasdaq-100 Index, with its private holdings contributing 11.92 percentage points, the company said in a statement.
“Anthropic showed what is possible when a fund like AGIX can get onto the cap table of a category-defining AI company early, and our goal is to keep finding the next opportunities like it,” said KraneShares Senior Investment Strategist, Derek Yan.
The company said AGIX became the first ETF to invest directly in Anthropic, the maker of the Claude AI models, in February 2025, at a valuation of US$61.5 billion. (US$1 = RM4.05)
KraneShares Head of Capital Markets and AGIX Portfolio Manager, James Maund said combining public AI stocks with direct stakes in private companies such as Anthropic allows investors to take part in these companies’ growth before they go public.
The update comes as Anthropic moves towards a stock market listing after filing with the United States Securities and Exchange Commission on Oct 26 to list on Nasdaq under the ticker “ANT”, according to KraneShares citing a Wall Street Journal report.
The fund also holds stakes in private companies including General Intuition, Ayar Labs, Standard Bots, Apptronik, and Nuro.
-- BERNAMA
DENODO, AWS SEAL MULTI-YEAR DEAL ON AI DATA ACCESS
The agreement builds on the companies’ existing relationship and includes joint workshops, co-marketing, co-selling and commercial incentives, as well as solutions with systems integrators for uses such as fraud prevention in banking, claims processing in insurance and predictive maintenance in manufacturing, Denodo said in a statement.
“Together with AWS, we give joint customers a unified AI data layer so that agents can access live, governed data and active context across every enterprise source, without moving or replicating it.
“This expanded collaboration helps our customers move from pilot to production in days rather than months and scale with confidence,” said Denodo Chief Executive Officer, Ángel Viña in a statement.
Meanwhile, AWS Director of Americas Technology Partners, Allison Johnson said the collaboration helps customers extend the value of their AWS AI investments to all their data, wherever it is stored.
Denodo’s software allows AWS AI services to use company data held in on-premises systems, other cloud services and software as a service (SaaS) applications without first copying or moving it.
Denodo is available as a fully managed cloud service or for deployment in customers’ own AWS accounts and can be bought through AWS Marketplace.
-- BERNAMA
InterSystems Joins Google Cloud as Launch Partner for Gemini for Healthcare
BOSTON, Nov 11 (Bernama-BUSINESS WIRE) -- InterSystems, a creative data technology provider powering more than one billion health records globally, today announced that it will serve as a launch partner for Google Cloud’s Gemini for healthcare. Through the collaboration, Gemini for healthcare will connect to the InterSystems IRIS FHIR Model Context Protocol (MCP) server, enabling healthcare organizations to give AI assistants and agents governed access to FHIR data.
The integration will bring together Google Cloud’s Gemini capabilities and the standards-based data access provided by InterSystems IRIS FHIR MCP. InterSystems FHIR MCP serves the open Model Context Protocol directly from a FHIR endpoint, allowing MCP-enabled clients to discover and use FHIR tools for searching, reading, creating, updating, and managing healthcare data.
“Healthcare organizations are looking for practical ways to apply AI to their data without compromising security, governance, or interoperability,” said Don Woodlock, president of InterSystems. “By connecting Gemini for healthcare with InterSystems IRIS FHIR MCP, we are establishing a trusted bridge between advanced AI and the health information these organizations rely on.”
“The leap from passive chatbots to agentic workflows depends entirely on interoperability. An AI agent is only as safe and competent as the pipeline feeding it,” said Aashima Gupta, global managing director, Healthcare Google Cloud. “Partnering with InterSystems grounds Gemini for healthcare in the bedrock of global healthcare data infrastructure, turning static medical records into active, governed intelligence that works safely at the bedside and beyond.”
About InterSystems
InterSystems, a creative data technology provider, delivers a unified foundation for next-generation applications for healthcare, finance, manufacturing, and supply chain customers in more than 80 countries. Our data platforms solve interoperability, speed, and scalability problems for large organizations around the globe to unlock the power of data and allow people to perceive data in imaginative ways. Established in 1978, InterSystems is committed to excellence through its 24×7 support for customers and partners around the world. Privately held and headquartered in Boston, Massachusetts, InterSystems has 38 offices in 28 countries worldwide. For more information, please visit InterSystems.com.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261110093577/en/
Contact
InterSystems PR Contact:
Zach Keating
pr@intersystems.com
617-551-5158
Source : InterSystems
Tuesday, November 10, 2026
VOCALBEATS.AI PARTNERS AI SINGAPORE ON APPRENTICE TRAINING
Under the partnership, which began in October, apprentices will work with the Vocalbeats.AI team on practical AI development projects, applying emerging technologies to real business and user needs, the company said in a statement.
“By working with AI Singapore, we hope to give apprentices meaningful exposure to our projects and share what we have learned from building AI products for a global audience,” said Vocalbeats.AI Chief Executive Officer, Marco Lai Jinnan.
Meanwhile, AISG Director of AI Innovation, Laurence Liew said the collaboration would give apprentices the chance to tackle real industry challenges and see how AI applications are developed and evaluated.
The apprenticeship programme combines structured training, mentorship and industry project experience to develop AI engineering skills.
The partnership builds on scholarships Vocalbeats.AI set up earlier this year at the National University of Singapore and Nanyang Technological University.
-- BERNAMA
YYFORCE HUMANOID ROBOT TRAINING FEATURED ON SINGAPORE TV
Hosted by veteran presenter Zhang Haijie, the television feature provided viewers with an in-depth, hands-on look at emerging humanoid robotics technologies and their practical commercial training workflows.
In the episode, presenter Zhang Haijie used a virtual reality headset and five motion sensors on his head, hands and feet to control a Unitree G1 humanoid robot in real time, with the system recording his movements to build training data for artificial intelligence (AI) models, the company said in a statement.
“Our vision is not about replacing people with robots. We are building toward an operating model where people, AI, humanoid robots and specialised service robots can work together, with each performing the functions where they can create the greatest value,” said YYForce Chief Executive Officer, Mike Fu.
The programme showed that teaching the robot to identify, pick up and move a cup on its own took 40 human demonstrations, followed by about eight hours of AI model training.
YYForce said it is training humanoid robots for tasks such as cleaning hotel rooms and restrooms and has set up robotics demonstration and training facilities in Singapore.
-- BERNAMA
HOLOGEN, SYSMEX FORM AI VENTURE TO ANALYSE BLOOD TEST DATA
Saibogen will apply Hologen’s Large Medicine Models, AI models that learn the biology behind real-world healthcare data, to data from Sysmex haematology analysers, which run about three billion blood count tests a year.
“Every routine blood count measures tens of thousands of cells with remarkable precision, and much of that information goes unused,” said Saibogen chief executive officer (CEO), Leila Luheshi.
The joint venture aims to give researchers and clinicians new insights without requiring new instruments, reagents or samples, according to a statement.
“Blood is one of the richest sources of biological information we have. Our Large Medicine Models are built to learn that biology from real-world data,” said Hologen CEO, Roland Tegeder.
Meanwhile, Sysmex president, Iwane Matsui said the venture would combine Sysmex’s haematology expertise and global business platform with Hologen’s AI technologies to unlock new value from routine blood testing data.
Saibogen’s products will be delivered as software exclusively through Sysmex’s haematology analysers, with its first offerings for research use only.
-- BERNAMA
Reality Partners with Merkl to Support rToken Dividend Distribution Across DeFi
VICTORIA, Seychelles, Nov 10 (Bernama-GLOBE NEWSWIRE) -- Reality, the tokenization platform bringing publicly listed equities onchain and part of the Bitget ecosystem, has partnered with Merkl to identify eligible rToken holders whose tokens are deployed across supported DeFi protocols. This will enable them to keep receiving dividends in stablecoin, even when their tokens are put to work in DeFi instead of sitting in a wallet.
rTokens provide tokenized exposure to publicly listed stocks and ETFs, including eligible economic benefits such as dividends. When these tokens are deposited into lending markets, liquidity pools or staking contracts, the smart contract may appear as the holder onchain instead of the individual user. This makes it more difficult to identify who should receive the associated dividend distributions.
Merkl’s reward forwarder technology addresses this by tracing token positions through supported smart contracts to identify the underlying holders and allocate distributions according to the applicable rules. The system can account for multiple layers of DeFi contracts and protocol-specific fees. Users and developers can check if individual contracts are supported through the Merkl Studio Forwarder Scan tool.
"The challenge with assets held in DeFi is knowing who sits behind each position," said Pablo Veyrat, CEO and Co-founder of Merkl. "Our forwarder technology traces ownership through nested smart contracts and tells Reality exactly who holds what, so dividends can reach the right people wherever their tokens are deployed."
"Tokenized equities should be useful beyond trading," said Gracy Chen, CEO of Bitget. "If someone puts their rTokens to work in DeFi, they should still be able to receive the dividends they’re eligible for. Working with Merkl helps us address that challenge and makes tokenized equities more practical for everyday use."
Under the partnership, Reality continues to manage rToken issuance and dividend entitlements, while Merkl provides the reward forwarding infrastructure for identifying eligible holders across supported DeFi positions. Reality’s rToken model distributes eligible cash dividends separately from the token’s price, with net cash dividends generally settled in USDT. Distribution through DeFi remains subject to the supported contracts and applicable distribution rules.
The partnership builds on the growing adoption of rTokens within Bitget’s UEX ecosystem. According to a DeFiLlama report, rToken trading volume reached $1.16 billion in cumulative volume between June and July, while the number of users trading both crypto and rTokens grew 23.54% month over month in July 2026, pointing to rising demand for tokenized equities as part of broader, cross-asset strategies. The integration with Merkl supports the next stage of development, helping extend the use of tokenized equities beyond exchange-based trading into DeFi.
About Reality
Reality is a regulated real-world asset issuance platform built for global markets, and is proudly part of the Bitget ecosystem. Working with licensed brokers across major exchanges, including Nasdaq and the NYSE, we purchase and hold the underlying assets in custody, then issue the corresponding rights on-chain. This connects traditional capital markets with on-chain infrastructure, opening institutional-grade access to real-world assets for users worldwide.
About Merkl
Merkl is the leading onchain money streaming platform. Stablecoin issuers, fintechs, neobanks and tokenized funds use Merkl to calculate and send yield, dividends and payouts. Merkl tracks ownership across lending markets, liquidity pools and other nested smart contracts, so every payment reaches the beneficial owner behind each position. Since launching in July 2023, Merkl has distributed over $1.8B in tokens across 60+ chains for more than 1,000 companies, including PayPal, Coinbase, Robinhood and Morpho.
For media inquiries, please contact: media@bitget.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cc2e8771-09cc-41d7-b3c3-d46f4533278f
SOURCE: Bitget Limited
DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.
--BERNAMA
Friday, November 6, 2026
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
Deal reflects a shared belief that site interoperability and dual submissions are key to unlocking the benefits of local manufacturing for a global supply
Running multiple sites as one integrated supply node lets both companies move production quickly between locations as needs change
COPENHAGEN, Denmark, Nov 4 (Bernama-GLOBE NEWSWIRE) -- AGC Biologics has expanded its existing long-term manufacturing agreement with a global pharmaceutical company, adding a second supply node at the CDMO’s Copenhagen facility. The expansion, which builds on the existing agreement anchored at AGC Biologics’ Yokohama site, grows the deal’s total value beyond €0.5 billion.
The expanded deal calls for multi-product drug substance manufacturing across six biologics programs at AGC Biologics’ Copenhagen site, encompassing process transfer, scale-up, validation, and commercial production. Products will launch and move across facilities with several dual regulatory submissions to optimize capacity, cost, and local manufacturing benefits, capturing levels of flexibility and supply chain robustness that could not be achieved with a single-site supply arrangement.
“This customer is building a more resilient, more flexible supply chain, and they’ve chosen to do that with us across two continents. This is exactly what we’re well-positioned to offer to a market craving geographic flexibility and regionalization, while retaining global supply,” said Alberto Santagostino, President and CEO of AGC Biologics. “We’ve built our single-use strategy around quality, capacity, and deep technical expertise so that when a partner is ready to localize and scale, we can meet them where they are. This deal takes inter-site flexibility to a larger scale, but it builds on our existing experience: two of our customers have already decided to co-launch their products from both our Seattle and Copenhagen facilities.”
This agreement further cements AGC Biologics as a prominent global player in single-use bioreactor manufacturing, serving the large-scale mammalian single-use manufacturing needs of major pharmaceutical companies across regions. AGC Biologics maintains one of the largest global networks of single-use manufacturing capacity by volume in the industry, according to BDO’s bioTRAK database. By combining strong commercialization capabilities with a friendly and expert CDMO approach, AGC Biologics supports customers pursuing cross-site launches, geographic flexibility, and regionalized manufacturing strategies across its global network.
“For a customer to bring six additional programs to Copenhagen, after bringing five to Yokohama, tells you everything about the trust our team has earned across the network,” said Tadashi Murano, President of AGC Life Science Company. “Our focus stays on building lasting and trust-based relationships with our pharmaceutical customers, like we have been doing for decades in AGC with our industrial partners across a wide range of industries including electronics and automotive.”
Frequently Asked Questions (FAQs)
Why isn't the customer named in this announcement?
Consistent with standard practice in the biopharmaceutical industry, customer names are not disclosed without the customer's consent. AGC Biologics regularly enters into confidential manufacturing agreements to protect its customers' competitive and regulatory strategies.
Could this customer expand its manufacturing relationship with AGC Biologics further?
AGC Biologics operates GMP manufacturing sites across the U.S., Europe, and Asia, providing capacity for customers to expand into additional regions as their commercial manufacturing needs evolve.
What does AGC Biologics’ Copenhagen site offer to large-scale developers?
Scientific teams at AGC Biologics’ Copenhagen site have 25 years of expertise in drug substance development and GMP manufacturing. Customers using the site have received a total of over 50 commercial approvals from more than 20 regulatory agencies.
The Copenhagen site expansion in 2024 included 18,000 square meters distributed across manufacturing, quality control laboratories and technical and warehouse areas, including:
- Eight 2,000-liter single-use bioreactor production lines
- One 500-liter perfusion bioreactor
- Two downstream purification lines
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, to provide friendly and expert services. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with locations in Seattle, Washington; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba and Yokohama, Japan. AGC Biologics is a part of AGC Inc.'s Life Science Business. The Life Science Business runs eight facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/4897a863-7a97-421e-80c6-ea973e3d314a
AGC Inc. corporate contact: info-pr@agc.com
AGC Biologics media contact: kati.sills@agc.com
SOURCE: AGC Biologics, Inc.
--BERNAMA